27 June 2023
Researchers from the University of Oxford's Livestock Environment and People (LEAP) programme look forward to engaging thousands of members of the public with leading research on the health and environmental impacts of meat consumption.
24 January 2023
Recently, Professor Chris Butler addressed the United Nations regarding the PANORAMIC Trial and the assistance of BAPS UK & Europe.
8 December 2021
Researchers from the University of Oxford have today started recruiting participants for a first-of-its-kind clinical trial to test novel antiviral COVID-19 treatments for use early on in the illness by people in the community with COVID-19 and those who are at higher risk of complications – partnering with the National Institute for Health Research (NIHR) and working with colleagues in several UK universities, and the NHS UK-wide.
16 July 2019
The projects will reach out to rural communities and black and ethnic minority groups - audiences who are seldom engaged in primary care research.
7 January 2019
In this episode of the Big Questions podcast, Dr Christina Potter in the Nuffield Department of Primary Care Health Sciences is asked "Should I be a vegan?"
7 November 2018
A Cochrane stakeholder engagement project led from the Nuffield Department of Primary Care Health Sciences informs national funding call for tobacco research.
22 January 2018
Crafting project awarded Oxford University Public Engagement Seed Funding.
28 November 2017
An exhibition of portraits commissioned to showcase the diversity of staff and past students at Oxford University features Professor Trish Greenhalgh.
7 September 2017
A new set of research priorities to support tobacco control will help ensure future research provides the greatest benefit to public health and value for money, according to an international group led by Oxford University researchers.
21 June 2017
Manifesto aims to develop more trustworthy evidence to improve healthcare
29 November 2016
The programme uncovers a lack of supporting evidence for claims about fertility treatment "add-ons", and is backed up by Oxford-led research reported in the BMJ.